Treatment with GBP, a widely used clinical pharmaceutical drug that is used for treatment of pain, anxiety and epilepsy, could disrupt the interaction of TSP with α2δ-1 and would prevent the formation of epileptic activity[30, 51]. The gene discussed is THBS1; the disease is Anxiety.